{"metabolisms": [{"drug_chembl_id": "CHEMBL417", "enzyme_name": null, "met_comment": null, "met_conversion": null, "met_id": 119, "metabolism_refs": [{"ref_id": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdf", "ref_type": "OTHER", "ref_url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdf"}], "metabolite_chembl_id": "CHEMBL3508152", "metabolite_name": "Doxorubicinol aglycone", "organism": "Homo sapiens", "pathway_id": 1, "pathway_key": "Fig. 2, p.19", "substrate_chembl_id": "CHEMBL3508141", "substrate_name": "Epidoxorubicinol, 4'-epiadriamycinol", "target_chembl_id": null, "tax_id": 9606}, {"drug_chembl_id": "CHEMBL417", "enzyme_name": null, "met_comment": null, "met_conversion": null, "met_id": 120, "metabolism_refs": [{"ref_id": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdf", "ref_type": "OTHER", "ref_url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdf"}], "metabolite_chembl_id": "CHEMBL3508144", "metabolite_name": "7d-Aon", "organism": "Homo sapiens", "pathway_id": 1, "pathway_key": "Fig. 2, p.19", "substrate_chembl_id": "CHEMBL417", "substrate_name": "Epirubicin", "target_chembl_id": null, "tax_id": 9606}, {"drug_chembl_id": "CHEMBL417", "enzyme_name": null, "met_comment": null, "met_conversion": null, "met_id": 121, "metabolism_refs": [{"ref_id": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdf", "ref_type": "OTHER", "ref_url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdf"}], "metabolite_chembl_id": "CHEMBL3508153", "metabolite_name": "Doxorubicin aglycone", "organism": "Homo sapiens", "pathway_id": 1, "pathway_key": "Fig. 2, p.19", "substrate_chembl_id": "CHEMBL417", "substrate_name": "Epirubicin", "target_chembl_id": null, "tax_id": 9606}, {"drug_chembl_id": "CHEMBL417", "enzyme_name": null, "met_comment": null, "met_conversion": null, "met_id": 122, "metabolism_refs": [{"ref_id": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdf", "ref_type": "OTHER", "ref_url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdf"}], "metabolite_chembl_id": "CHEMBL6067664", "metabolite_name": "Epirubicin glucuronide", "organism": "Homo sapiens", "pathway_id": 1, "pathway_key": "Fig. 2, p.19", "substrate_chembl_id": "CHEMBL417", "substrate_name": "Epirubicin", "target_chembl_id": null, "tax_id": 9606}, {"drug_chembl_id": "CHEMBL417", "enzyme_name": null, "met_comment": null, "met_conversion": null, "met_id": 123, "metabolism_refs": [{"ref_id": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdf", "ref_type": "OTHER", "ref_url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdf"}], "metabolite_chembl_id": "CHEMBL3508141", "metabolite_name": "Epidoxorubicinol, 4'-epiadriamycinol", "organism": "Homo sapiens", "pathway_id": 1, "pathway_key": "Fig. 2, p.19", "substrate_chembl_id": "CHEMBL417", "substrate_name": "Epirubicin", "target_chembl_id": null, "tax_id": 9606}, {"drug_chembl_id": "CHEMBL417", "enzyme_name": null, "met_comment": null, "met_conversion": null, "met_id": 124, "metabolism_refs": [{"ref_id": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdf", "ref_type": "OTHER", "ref_url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdf"}], "metabolite_chembl_id": "CHEMBL6067664", "metabolite_name": "Epirubicinol glucuronide", "organism": "Homo sapiens", "pathway_id": 1, "pathway_key": "Fig. 2, p.19", "substrate_chembl_id": "CHEMBL3508141", "substrate_name": "Epidoxorubicinol, 4'-epiadriamycinol", "target_chembl_id": null, "tax_id": 9606}, {"drug_chembl_id": "CHEMBL417", "enzyme_name": null, "met_comment": null, "met_conversion": null, "met_id": 125, "metabolism_refs": [{"ref_id": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdf", "ref_type": "OTHER", "ref_url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdf"}], "metabolite_chembl_id": "CHEMBL3508143", "metabolite_name": "7d-Aolon", "organism": "Homo sapiens", "pathway_id": 1, "pathway_key": "Fig. 2, p.19", "substrate_chembl_id": "CHEMBL3508141", "substrate_name": "Epidoxorubicinol, 4'-epiadriamycinol", "target_chembl_id": null, "tax_id": 9606}, {"drug_chembl_id": "CHEMBL1639", "enzyme_name": null, "met_comment": null, "met_conversion": "O-dealkylation", "met_id": 127, "metabolism_refs": [{"ref_id": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P2.pdf", "ref_type": "OTHER", "ref_url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P2.pdf"}, {"ref_id": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P3.pdf", "ref_type": "OTHER", "ref_url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P3.pdf"}], "metabolite_chembl_id": "CHEMBL3507701", "metabolite_name": "Metabolite M4", "organism": "Homo sapiens", "pathway_id": 3, "pathway_key": "Fig. 9, p164/165", "substrate_chembl_id": "CHEMBL1639", "substrate_name": "Aliskiren, SPP100", "target_chembl_id": null, "tax_id": 9606}, {"drug_chembl_id": "CHEMBL1639", "enzyme_name": null, "met_comment": null, "met_conversion": "O-demethylation of the methoxypropoxy side chain", "met_id": 128, "metabolism_refs": [{"ref_id": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdf", "ref_type": "OTHER", "ref_url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdf"}], "metabolite_chembl_id": "CHEMBL3507701", "metabolite_name": "Metabolite M4", "organism": "Callithrix jacchus", "pathway_id": 2, "pathway_key": "Fig. 2.1.4.1, p.46", "substrate_chembl_id": "CHEMBL1639", "substrate_name": "Aliskiren, SPP100", "target_chembl_id": null, "tax_id": 9483}, {"drug_chembl_id": "CHEMBL1639", "enzyme_name": null, "met_comment": null, "met_conversion": "Oxidative dealkylation", "met_id": 129, "metabolism_refs": [{"ref_id": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdf", "ref_type": "OTHER", "ref_url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdf"}], "metabolite_chembl_id": "CHEMBL3507701", "metabolite_name": "Metabolite M4", "organism": "Homo sapiens", "pathway_id": 1, "pathway_key": "Fig. 2, p.19", "substrate_chembl_id": "CHEMBL1639", "substrate_name": "Aliskiren, SPP100", "target_chembl_id": null, "tax_id": 9606}, {"drug_chembl_id": "CHEMBL1639", "enzyme_name": null, "met_comment": "Species: Figure legend also mentions Rattus norvegicus.", "met_conversion": null, "met_id": 130, "metabolism_refs": [{"ref_id": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdf", "ref_type": "OTHER", "ref_url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdf"}], "metabolite_chembl_id": "CHEMBL3507701", "metabolite_name": "Metabolite M4", "organism": "Mus musculus", "pathway_id": 1, "pathway_key": "Fig. 2.1.1.1, p.35", "substrate_chembl_id": "CHEMBL3507700", "substrate_name": "Metabolite M3", "target_chembl_id": null, "tax_id": 10090}, {"drug_chembl_id": "CHEMBL1639", "enzyme_name": null, "met_comment": "Species: Figure legend also mentions Rattus norvegicus.", "met_conversion": null, "met_id": 131, "metabolism_refs": [{"ref_id": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdf", "ref_type": "OTHER", "ref_url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdf"}], "metabolite_chembl_id": "CHEMBL3507701", "metabolite_name": "Metabolite M4", "organism": "Mus musculus", "pathway_id": 1, "pathway_key": "Fig. 2.1.1.1, p.35", "substrate_chembl_id": "CHEMBL3507697", "substrate_name": "Metabolite M2", "target_chembl_id": null, "tax_id": 10090}, {"drug_chembl_id": "CHEMBL1639", "enzyme_name": null, "met_comment": "Species: Figure legend also mentions Rattus norvegicus.", "met_conversion": "C-oxidation", "met_id": 132, "metabolism_refs": [{"ref_id": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdf", "ref_type": "OTHER", "ref_url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdf"}], "metabolite_chembl_id": "CHEMBL3507697", "metabolite_name": "Metabolite M2", "organism": "Mus musculus", "pathway_id": 1, "pathway_key": "Fig. 2.1.1.1, p.35", "substrate_chembl_id": "CHEMBL3507700", "substrate_name": "Metabolite M3", "target_chembl_id": null, "tax_id": 10090}, {"drug_chembl_id": "CHEMBL1639", "enzyme_name": null, "met_comment": null, "met_conversion": "Oxidation", "met_id": 133, "metabolism_refs": [{"ref_id": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdf", "ref_type": "OTHER", "ref_url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdf"}], "metabolite_chembl_id": "CHEMBL3507697", "metabolite_name": "Metabolite M2", "organism": "Callithrix jacchus", "pathway_id": 2, "pathway_key": "Fig. 2.1.4.1, p.46", "substrate_chembl_id": "CHEMBL3507700", "substrate_name": "Metabolite M3", "target_chembl_id": null, "tax_id": 9483}, {"drug_chembl_id": "CHEMBL1639", "enzyme_name": null, "met_comment": null, "met_conversion": "Oxidation", "met_id": 134, "metabolism_refs": [{"ref_id": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P2.pdf", "ref_type": "OTHER", "ref_url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P2.pdf"}, {"ref_id": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P3.pdf", "ref_type": "OTHER", "ref_url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P3.pdf"}], "metabolite_chembl_id": "CHEMBL3507697", "metabolite_name": "Metabolite M2", "organism": "Homo sapiens", "pathway_id": 3, "pathway_key": "Fig. 9, p164/165", "substrate_chembl_id": "CHEMBL3507700", "substrate_name": "Metabolite M3", "target_chembl_id": null, "tax_id": 9606}, {"drug_chembl_id": "CHEMBL1639", "enzyme_name": null, "met_comment": "Species: Figure legend also mentions Rattus norvegicus.", "met_conversion": null, "met_id": 135, "metabolism_refs": [{"ref_id": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdf", "ref_type": "OTHER", "ref_url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdf"}], "metabolite_chembl_id": "CHEMBL3507697", "metabolite_name": "Metabolite M2", "organism": "Mus musculus", "pathway_id": 1, "pathway_key": "Fig. 2.1.1.1, p.35", "substrate_chembl_id": "CHEMBL1639", "substrate_name": "Aliskiren, SPP100", "target_chembl_id": null, "tax_id": 10090}, {"drug_chembl_id": "CHEMBL1639", "enzyme_name": null, "met_comment": "Species: Figure legend also mentions Rattus norvegicus.", "met_conversion": "Glucuronidation", "met_id": 136, "metabolism_refs": [{"ref_id": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdf", "ref_type": "OTHER", "ref_url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdf"}], "metabolite_chembl_id": "CHEMBL3507696", "metabolite_name": "Metabolite M5", "organism": "Mus musculus", "pathway_id": 1, "pathway_key": "Fig. 2.1.1.1, p.35", "substrate_chembl_id": "CHEMBL3507699", "substrate_name": "Metabolite M1", "target_chembl_id": null, "tax_id": 10090}, {"drug_chembl_id": "CHEMBL1639", "enzyme_name": null, "met_comment": "Species: Figure legend also mentions Rattus norvegicus.", "met_conversion": "Glucuronidation", "met_id": 137, "metabolism_refs": [{"ref_id": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdf", "ref_type": "OTHER", "ref_url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdf"}], "metabolite_chembl_id": "CHEMBL3507695", "metabolite_name": "Metabolite M6", "organism": "Mus musculus", "pathway_id": 1, "pathway_key": "Fig. 2.1.1.1, p.35", "substrate_chembl_id": "CHEMBL3507701", "substrate_name": "Metabolite M4", "target_chembl_id": null, "tax_id": 10090}, {"drug_chembl_id": "CHEMBL1639", "enzyme_name": null, "met_comment": null, "met_conversion": "O-glucuronidation", "met_id": 138, "metabolism_refs": [{"ref_id": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P2.pdf", "ref_type": "OTHER", "ref_url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P2.pdf"}, {"ref_id": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P3.pdf", "ref_type": "OTHER", "ref_url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P3.pdf"}], "metabolite_chembl_id": "CHEMBL3507695", "metabolite_name": "Metabolite M6", "organism": "Homo sapiens", "pathway_id": 3, "pathway_key": "Fig. 9, p164/165", "substrate_chembl_id": "CHEMBL3507701", "substrate_name": "Metabolite M4", "target_chembl_id": null, "tax_id": 9606}, {"drug_chembl_id": "CHEMBL1639", "enzyme_name": null, "met_comment": null, "met_conversion": null, "met_id": 139, "metabolism_refs": [{"ref_id": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P2.pdf", "ref_type": "OTHER", "ref_url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P2.pdf"}, {"ref_id": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P3.pdf", "ref_type": "OTHER", "ref_url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P3.pdf"}], "metabolite_chembl_id": "CHEMBL3507701", "metabolite_name": "Metabolite M4", "organism": "Homo sapiens", "pathway_id": 3, "pathway_key": "Fig. 9, p164/165", "substrate_chembl_id": "CHEMBL3507697", "substrate_name": "Metabolite M2", "target_chembl_id": null, "tax_id": 9606}], "page_meta": {"limit": 20, "next": "/chembl/api/data/metabolism.json?limit=20&offset=20", "offset": 0, "previous": null, "total_count": 2147}}